Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

185.42
BATS BZX Real-Time Price
As of 1:13pm ET
 +2.92 / +1.60%
Today’s Change
128.50
Today|||52-Week Range
314.88
+18.86%
Year-to-Date

Today’s Trading

Previous close182.50
Today’s open188.00
Day’s range183.02 - 189.45
Volume153,437
Average volume (3 months)356,306
Market cap$4.4B
Dividend yield--
Data as of 1:02pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+23.43%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book16.93

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc+0.40+1.04%
RAREUltragenyx Pharmaceu...+1.85+1.67%
HZNPHorizon Pharma PLC+0.72+2.48%
NBIXNeurocrine Bioscienc...+0.95+2.02%
Data as of 1:17pm ET, 09/02/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$2.78
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

Partner Offers